The bill, known as Senate Bill No. 109, mandates that health benefit plans in Oklahoma, including the Oklahoma Employees Insurance Plan, provide coverage for specific genetic testing and cancer imaging. It defines key terms such as "clinical utility," "evidence-based cancer imaging," and "genetic testing for an inherited mutation." The bill requires that clinical genetic testing be available for individuals with a personal or family history of cancer, provided it demonstrates clinical utility and is ordered by a healthcare provider based on established medical guidelines. Additionally, it stipulates that evidence-based cancer imaging must be covered for individuals at increased risk of cancer under similar conditions.

Furthermore, the bill specifies that coverage for these services will not be subject to annual deductibles, copayments, or coinsurance limits. It also addresses the implications for health savings accounts, stating that the provisions will apply to qualified high deductible health plans after the minimum deductible is met, while preventive care services will be covered regardless of deductible status. The act is set to take effect on November 1, 2025.